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phenylketonuria (the PICO study): a
randomized, placebo-controlled, crossover,
noninferiority trial
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Correction to: Trials (2020) 21:178
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Following publication of the original article [1], the
authors notified us that Fig. 1 was incorrect.
The corrected Fig. 1 is presented below.
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Fig. 1 Study flow chart. Legend. T0 = screening; T1 = first assessment; T2 = second assessment; T3 = third assessment; T4 = fourth and last assessment
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